Jefferies upgrades Disney to “buy,” raises price target to $144
Jefferies upgrades Disney to “buy,” raises price target to $144
Source link
Similar Posts
Verastem’s Path To FDA Approval: High-Risk, High-Reward Oncology Opportunity (NASDAQ:VSTM)
KatarzynaBialasiewicz/iStock via Getty Images Verastem, Inc. (NASDAQ:VSTM) is a clinical-stage biopharmaceutical company that develops cancer treatments targeting the RAS/MAPK pathway. This cell growth modulator is useful for pancreatic, lung, colorectal, and low-grade serous ovarian cancers (LGSOC). The company’s leading therapy combines Avutometinib and Defactinib, which offer complementary mechanisms of action to disrupt malignant cell growth…
Ericsson Falls Short of Estimates as Sales in India Struggle – Equitypandit
January 24, 2025January 24, 2025 Ericsson AB’s earnings missed analysts’ expectations in the fourth quarter, as sales to India did not recover as anticipated. Ericsson’s adjusted earnings for Q4 were 9.8 billion Swedish kronor ($894 million), up 33% from last year, but missed analysts’ estimate of 10.3 billion kronor….
Israel stocks higher at close of trade; TA 35 up 2.60% By Investing.com
Investing.com – Israel stocks were higher after the close on Sunday, as gains in the , and sectors led shares higher. At the close in Tel Aviv, the gained 2.60% to hit a new all time high. The best performers of the session on the were NICE Ltd (TASE:), which rose 8.81% or 5,790.00 points…
BEML shares in focus after bagging 2 work orders worth $6.23 million
BEML Ltd shares are likely to be in focus on Monday, following the company’s announcement that it has secured two export orders worth approximately USD 6.23 million, as per its regulatory filing. The state-run defense and heavy equipment manufacturer announced that it has received one order from the Commonwealth of Independent States (CIS) region for…
